Correlation Between ANI Pharmaceuticals and SIMCERE PHARMAC

Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and SIMCERE PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and SIMCERE PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ANI Pharmaceuticals and SIMCERE PHARMAC GRP, you can compare the effects of market volatilities on ANI Pharmaceuticals and SIMCERE PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of SIMCERE PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and SIMCERE PHARMAC.

Diversification Opportunities for ANI Pharmaceuticals and SIMCERE PHARMAC

-0.64

Correlation Coefficient

ANI Pharmaceuticals  SIMCERE PHARMAC

Excellent diversification

The 3 months correlation between ANI and SIMCERE is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and SIMCERE PHARMAC GRP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIMCERE PHARMAC GRP and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with SIMCERE PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIMCERE PHARMAC GRP has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and SIMCERE PHARMAC go up and down completely randomly.

Pair Corralation between ANI Pharmaceuticals and SIMCERE PHARMAC

Assuming the 90 days trading horizon ANI Pharmaceuticals is expected to under-perform the SIMCERE PHARMAC. But the stock apears to be less risky and, when comparing its historical volatility, ANI Pharmaceuticals is 1.98 times less risky than SIMCERE PHARMAC. The stock trades about -0.05 of its potential returns per unit of risk. The SIMCERE PHARMAC GRP is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  95.00  in SIMCERE PHARMAC GRP on April 23, 2025 and sell it today you would earn a total of  35.00  from holding SIMCERE PHARMAC GRP or generate 36.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ANI Pharmaceuticals  vs.  SIMCERE PHARMAC GRP

ANI Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

SIMCERE PHARMAC GRP

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in SIMCERE PHARMAC GRP are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, SIMCERE PHARMAC reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ANI Pharmaceuticals and SIMCERE PHARMAC

The main advantage of trading using opposite ANI Pharmaceuticals and SIMCERE PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, SIMCERE PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIMCERE PHARMAC will offset losses from the drop in SIMCERE PHARMAC's long position.

The idea behind ANI Pharmaceuticals and SIMCERE PHARMAC GRP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.